Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Tziomalos, K. (2014).  Lipid-lowering agents in the management of nonalcoholic fatty liver disease.. World J Hepatol. 6(10), 738-44.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Pavlidis A., Papadopoulou M., et al. (2013).  Effect of prior treatment with different statins on stroke severity and functional outcome at discharge in patients with acute ischemic stroke.. Int J Stroke. 8(7), E49.
Tziomalos, K., Giampatzis V., Baltatzi M., Efthymiou E., Psianou K., Papastergiou N., et al. (2014).  Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients.. J Clin Hypertens (Greenwich). 16(4), 309-12.
Tziomalos, K., Athyros V. G., Mikhailidis D. P., & Karagiannis A. (2013).  Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension.. Curr Pharm Des. 19(21), 3766-72.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2007).  Endothelial function, arterial stiffness and lipid lowering drugs.. Expert Opin Ther Targets. 11(9), 1143-60.
Tziomalos, K., Athyros V. G., & Mikhailidis D. P. (2009).  Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus.. Nat Clin Pract Endocrinol Metab. 5(1), 16-7.
Tziomalos, K., Katsikis I., Papadakis E., Kandaraki E. A., Macut D., & Panidis D. (2013).  Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.. Hum Reprod. 28(3), 785-93.
Tziomalos, K. (2009).  Combination treatment in HBeAg-negative chronic hepatitis B.. World J Hepatol. 1(1), 43-7.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2010).  Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.. Nutr Metab Cardiovasc Dis. 20(2), 140-6.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Papadopoulou M., Kostaki S., et al. (2015).  Elevated diastolic but not systolic blood pressure increases mortality risk in hypertensive but not normotensive patients with acute ischemic stroke.. Am J Hypertens. 28(6), 765-71.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.. Cerebrovasc Dis. 41(5-6), 226-32.
Tziomalos, K., Karagiannis A., & Athyros V. G. (2014).  Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure.. Curr Pharm Des. 20(40), 6306-13.
Tziomalos, K. (2017).  Barriers to insulin treatment in patients with type 2 diabetes mellitus.. Expert Opin Pharmacother. 18(3), 233-234.
Tziomalos, K., Vakalopoulou S., Perifanis V., & Garipidou V. (2009).  Treatment of congenital fibrinogen deficiency: overview and recent findings.. Vasc Health Risk Manag. 5, 843-8.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2015).  Cardiovascular Risk in Middle East Populations: A Call to Action.. Angiology. 66(9), 801-2.
Tziomalos, K., Florentin M., Krikis N., Perifanis V., Karagiannis A., & Harsoulis F. (2007).  Persistent effect of zoledronic acid in Paget's disease.. Clin Exp Rheumatol. 25(3), 464-6.
Tziomalos, K., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., Giampatzis V., et al. (2015).  Prior treatment with dipeptidyl peptidase 4 inhibitors is associated with better functional outcome and lower in-hospital mortality in patients with type 2 diabetes mellitus admitted with acute ischaemic stroke.. Diab Vasc Dis Res. 12(6), 463-6.
Tziomalos, K., Ganotakis E. S., Gazi I. F., Nair D. R., & Mikhailidis D. P. (2009).  Kidney function and estimated vascular risk in patients with primary dyslipidemia.. Open Cardiovasc Med J. 3, 57-68.
Tziomalos, K., Spanou M., Bouziana S. D., Papadopoulou M., Giampatzis V., Kostaki S., et al. (2014).  Type 2 diabetes is associated with a worse functional outcome of ischemic stroke.. World J Diabetes. 5(6), 939-44.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Dyslipidemia induced by drugs used for the prevention and treatment of vascular diseases.. Open Cardiovasc Med J. 5, 85-9.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Papadopoulou M., Kostaki S., et al. (2015).  Response to "Brachial Systolic Blood Pressure Fails to Predict Short-Term Outcome in Patients With Acute Ischemic Stroke: What About Central Systolic Pressure?".. Am J Hypertens. 28(9), 1181.
Tziomalos, K., Krassas G. E., & Tzotzas T. (2009).  The use of sibutramine in the management of obesity and related disorders: an update.. Vasc Health Risk Manag. 5(1), 441-52.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2015).  Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke.. Atherosclerosis. 243(1), 65-70.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2017).  Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke.. Clin Exp Hypertens. 39(3), 246-250.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke.. Blood Coagul Fibrinolysis. 27(2), 185-9.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές